DRW Securities’s Cascadian Therapeutics, Inc. CASC Stock Holding History

DRW Securities’s Portfolio CASC Stock Details CASC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-13,000	Closed	-$48K	–	528
2017 Q4	$48K	Buy	+13,000	New	+$53.2K	0.01%	450
2016 Q1	–	Sell	-85,279	Closed	-$1.14M	–	97
2015 Q4	$1.14M	Buy	+85,279	New	+$1.47M	0.11%	24

DRW Securities's CASC Position: Q1 2018 in Review

DRW Securities sold out of Cascadian Therapeutics, Inc. (CASC) in Q1 2018, closing a stake of 13,000 shares — an estimated $48K sold.

DRW Securities first reported a position in CASC in Q4 2015 and held it in 2 quarters. The position peaked at $1.14M in Q4 2015. 1 fund tracked by Wall St. Rank holds CASC as of Q1 2018.

DRW Securities reported no remaining Cascadian Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
DRW Securities sold 13,000 Cascadian Therapeutics, Inc. shares in Q1 2018, an estimated $48K.
DRW Securities first reported a position in Cascadian Therapeutics, Inc. in Q4 2015 and held it in 2 quarters.
DRW Securities's Cascadian Therapeutics, Inc. position peaked at $1.14M in Q4 2015.
1 fund tracked by Wall St. Rank held Cascadian Therapeutics, Inc. as of Q1 2018.

Based on DRW Securities's 13F filing for Q1 2018, filed 14 May 2018.